# Boris Bernstein

> Boris Bernstein is a Series B investor at MIG Capital (Munich) backing Health Care and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [MIG Capital](https://shizune.co/investors/profile/mig-ag)
- Location: Munich, Germany
- Total investments: 3
- Last investment: Nov 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/boris-bernstein-08aa42a/
- Website: https://www.mig.ag/en/mig-ag-team.html

Boris Bernstein is a Venture Partner at MIG Verwaltungs AG. He spent 10 years at Goldman Sachs in London as Executive Director in Investment Research. Subsequently he joined Allianz Capital Partners as Investment Manager, where he drove forward healthcare private equity investments. Most recently, he supported Water Street Healthcare Partners asExecutive Advisor and advised several family offices and mid market companies on strategy and investment questions. Boris Bernstein holds an MSc from the Georgetown University School of Foreign Service and a BA from Harvard University. He is Chartered Financial Analyst and Chairman of the CFA Society Germany.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Software | 1 | 33% |
| Medical Device | 1 | 33% |
| Personal Health | 1 | 33% |
| Consumer Electronics | 1 | 33% |

7 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Temedica | Temedica is a technology-, AI-, and data-enabled solutions and services provider for the pharma industry, based in Munich. Since 2016, it empowers pharma companies to achieve exceptional brand performance through holistic strategies and tactical execution. Leveraging real‐world insights, configurable AI-powered solutions, and deep medical andcommercial expertise, Temedica transforms pharma’s go-to-market challenges into measurable success. | $26M | Series B | Nov 23, 2022 |  |
| Mimi Hearing Technologies | Mimi is the world's leading company for digital hearing tests and sound personalization. The Mimi apps are medical devices in Europe (CE, class 1). With over one million hearing test app downloads from 150 countries, it creates the world’s largest database of digital hearing profiles. With Mimi Defined™, a technology for sound personalizationcould be developed, which - despite the imperfections of human hearing - can optimize the individual hearing experience for everyone. Our software can be integrated into any audio product, from headphones to TVs, smartphones or streaming services. Mimi Hearing Technologies products and integrations have won numerous prestigious international awards, including the CES Innovation Award in Las Vegas (2019 & 2018), the Sonar+D Award for Innovation in Barcelona (2017), the StartUps & Developer Award at the San Francisco Music Tech Summit (2017), the IFA Berlin Prize for Audio Innovation (2017), first place in the Cannes Midem lab competition in the category "Music Discovery" (2016), and the company was a finalist at the Techcrunch Disrupt New York Startup Battlefield in 2014. More information at www.mimi.io | $25M | Series B | Dec 15, 2021 |  |
| Mimi Hearing Technologies | Mimi is the world's leading company for digital hearing tests and sound personalization. The Mimi apps are medical devices in Europe (CE, class 1). With over one million hearing test app downloads from 150 countries, it creates the world’s largest database of digital hearing profiles. With Mimi Defined™, a technology for sound personalizationcould be developed, which - despite the imperfections of human hearing - can optimize the individual hearing experience for everyone. Our software can be integrated into any audio product, from headphones to TVs, smartphones or streaming services. Mimi Hearing Technologies products and integrations have won numerous prestigious international awards, including the CES Innovation Award in Las Vegas (2019 & 2018), the Sonar+D Award for Innovation in Barcelona (2017), the StartUps & Developer Award at the San Francisco Music Tech Summit (2017), the IFA Berlin Prize for Audio Innovation (2017), first place in the Cannes Midem lab competition in the category "Music Discovery" (2016), and the company was a finalist at the Techcrunch Disrupt New York Startup Battlefield in 2014. More information at www.mimi.io | $25M | Series B | Dec 15, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [ABACON](https://shizune.co/investors/profile/abacon-capital) — VC Fund, 2 deals together
- [Atlantic](https://shizune.co/investors/profile/atlantic-labs) — VC Fund, 2 deals together
- [Salvia](https://shizune.co/investors/profile/salvia-gmbh) — VC Fund, 2 deals together
- [MIG Capital](https://shizune.co/investors/profile/mig-asset-management) — VC Fund, 1 deal together
- [MIG Capital](https://shizune.co/investors/profile/mig-capital) — VC Fund, 1 deal together

## About MIG Capital

VC Fund · München, Germany

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

5 contacts available at MIG Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Axel Thierauf | Venture Partner | https://shizune.co/investors/profile/axel-thierauf |
| Boris Bernstein | Venture Partner | https://shizune.co/investors/profile/boris-bernstein |
| Dr. Klaus Feix | Venture Partner | https://shizune.co/investors/profile/dr-klaus-feix |
| Frederick Michna | Principal | https://shizune.co/investors/profile/frederick-michna |
| Jürgen Kosch | General Partner | https://shizune.co/investors/profile/jrgen-kosch |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Boris Bernstein invest in?

Boris Bernstein invests primarily in Health Care, Software and Medical Device startups, most often at Series B stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Boris Bernstein last invest?

The most recent investment recorded for Boris Bernstein closed in Nov 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co